Previous 10 | Next 10 |
Invitae Corporation (NVTA) Q2 2020 Earnings Conference Call August 4, 2020 4:30 PM ET Company Participants Laura D'Angelo – Head of Investor Relations Sean George – Chief Executive Officer Shelly Guyer – Chief Financial Officer Lee Bendekgey – Chief ...
SAN FRANCISCO , Aug. 4, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it granted restricted stock units ("RSUs") to Kenneth D. Knight , Invitae's new Chief Operating Officer and Karthik Suri , Invitae's new Chief Digital ...
Invitae (NYSE: NVTA ) : Q2 Non-GAAP EPS of -$0.77 misses by $0.05 ; GAAP EPS of -$1.29 misses by $0.57 . Revenue of $46.19M (-13.6% Y/Y) beats by $6.56M . Shares -4.6% . Press Release More news on: Invitae Corporation, Earnings news and commentary, Healthcare stocks news,
SAN FRANCISCO , Aug. 4, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended June 30, 2020 . "While we experienced significant disruptions in the health...
CRISPR Therapeutics (NASDAQ: CRSP) may be one of the best biotechnology stocks to own in 2020. It's one of a few companies leading the way in gene-editing therapies, a market that the analysts at MarketsandMarkets expect will be worth $11.2 billion by 2025. CRISPR's shares are up about 50% ...
SAN FRANCISCO , July 21, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2020 financial results on Tuesday, August 4, 2020 and will host a conference call and webcast that day at ...
By Michael Cintolo , Cabot Heritage Corporation GenMark ( GNMK ) is a testing company. Its proprietary eSensor detection technology (dubbed eSensor XT-8) and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations, and s...
NEW YORK, NY / ACCESSWIRE / July 8, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed t...
NEW YORK , July 8, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City , is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn ...
( Pexels ) Of all the investable sectors and industries, one of the top-performing over the past few months is biotechnology. Since its March low (18 th ), the SPDR Biotech ETF ( XBI ) has risen about 75% as investors speculate on virus treatment and vaccine rumors. Understandably, many in...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...